Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Sci Rep ; 12(1): 1903, 2022 02 03.
Artigo em Inglês | MEDLINE | ID: mdl-35115663

RESUMO

Xenopus laevis tadpoles possess high regenerative ability and can regenerate functional tails after amputation. An early event in regeneration is the induction of undifferentiated cells that form the regenerated tail. We previously reported that interleukin-11 (il11) is upregulated immediately after tail amputation to induce undifferentiated cells of different cell lineages, indicating a key role of il11 in initiating tail regeneration. As Il11 is a secretory factor, Il11 receptor-expressing cells are thought to mediate its function. X. laevis has a gene annotated as interleukin 11 receptor subunit alpha on chromosome 1L (il11ra.L), a putative subunit of the Il11 receptor complex, but its function has not been investigated. Here, we show that nuclear localization of phosphorylated Stat3 induced by Il11 is abolished in il11ra.L knocked-out culture cells, strongly suggesting that il11ra.L encodes an Il11 receptor component. Moreover, knockdown of il11ra.L impaired tadpole tail regeneration, suggesting its indispensable role in tail regeneration. We also provide a model showing that Il11 functions via il11ra.L-expressing cells in a non-cell autonomous manner. These results highlight the importance of il11ra.L-expressing cells in tail regeneration.


Assuntos
Proliferação de Células , Subunidade alfa de Receptor de Interleucina-11/metabolismo , Larva/metabolismo , Regeneração , Cauda/metabolismo , Proteínas de Xenopus/metabolismo , Xenopus laevis/metabolismo , Animais , Linhagem Celular , Proliferação de Células/efeitos dos fármacos , Regulação da Expressão Gênica no Desenvolvimento , Interleucina-11/farmacologia , Subunidade alfa de Receptor de Interleucina-11/agonistas , Subunidade alfa de Receptor de Interleucina-11/genética , Larva/efeitos dos fármacos , Larva/genética , Larva/crescimento & desenvolvimento , Fosforilação , Regeneração/efeitos dos fármacos , Fator de Transcrição STAT3/metabolismo , Transdução de Sinais , Cauda/efeitos dos fármacos , Cauda/embriologia , Proteínas de Xenopus/genética , Xenopus laevis/embriologia , Xenopus laevis/genética
2.
J Cell Physiol ; 232(12): 3565-3573, 2017 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-28112392

RESUMO

We previously described albumin endocytosis through caveolae in human renal glomerular endothelial cells (HRGECs). This suggested a new albumin transcytosis pathway, in addition to the fenestral pathway. As a next step, we investigated albumin transcytosis in HRGECs after caveolar endocytosis. HRGECs were incubated with Alexa Fluor 488-labeled bovine serum albumin from 0 to 360 min. Next, markers for endosomes, endoplasmic reticulum (ER), golgi apparatus (GA), lysosomes, and proteasomes and Fc receptors, microtubules, and actin were monitored by immunofluorescence. Labeled albumin co-localization with endosomes was gradually and significantly increased and it was significantly higher than with the other markers at any timepoint. Albumin, placed on inside of the Transwell membrane, diffused through HRGEC monolayers during a 360 min incubation period. This transportation of albumin through HRGECs was inhibited by methyl beta cyclodextrin (MBCD), a caveolae disrupting agent. MBCD also decreased albuminuria, causing decreased caveolin-1 (Cav-1) expression on glomerular capillaries, in puromycin aminonucleoside induced nephrotic mice. Albumin transcytosis depends on early endosomes, but not on other organelles, Fc receptors, or cytoskeletal components. Caveolae disruption prevented albumin transportation through HRGECs and decreased albuminuria in nephrotic mice. This newly described caveolae-dependent albumin pathway through glomerular endothelial cells is a potential pathogenetic mechanism for albuminuria, independent of the fenestrae.


Assuntos
Albuminúria/metabolismo , Cavéolas/metabolismo , Endocitose , Endossomos/metabolismo , Células Endoteliais/metabolismo , Glomérulos Renais/irrigação sanguínea , Soroalbumina Bovina/metabolismo , Transcitose , Albuminúria/induzido quimicamente , Albuminúria/prevenção & controle , Animais , Cavéolas/efeitos dos fármacos , Caveolina 1/metabolismo , Células Cultivadas , Modelos Animais de Doenças , Endocitose/efeitos dos fármacos , Endossomos/efeitos dos fármacos , Células Endoteliais/efeitos dos fármacos , Humanos , Masculino , Camundongos Endogâmicos C57BL , Nefrose/induzido quimicamente , Nefrose/metabolismo , Puromicina Aminonucleosídeo , Fatores de Tempo , Transcitose/efeitos dos fármacos , beta-Ciclodextrinas/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA